Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

This year, emergency departments nationwide are seeing an unusually early surge in very young and elderly patients with respiratory distress, often caused by respiratory syncytial virus or RSV. We ...

Respiratory syncytial virus is a seasonal respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older ...

However, older adult are more likely to have severe outcomes from the virus because the immune system typically weakens as we age. Each year, approximately 177,000 adults aged 65 and older are ...

Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug ...

Around the country, pediatric hospital wards are filled with children fighting a virus few adults know much about. Respiratory syncytial virus, which infects nearly everyone by age 2, usually goes ...

Respiratory Syncytial Virus, more commonly known as RSV, is plaguing hospitals all across the country.Although the virus is seen in children each year, it's being seen especially early this year.

A vaccine for adults 60 years and older was approved by the FDA for protection against respiratory syncytial virus, making it the first such vaccine to be approved worldwide.

This trend is similar to the higher-than-normal case rates of respiratory syncytial virus, or RSV, and influenza in the fall of 2022 and winter of 2023, likely related to decreased population ...

Respiratory syncytial virus can infect the throat, nose, lungs, and breathing passages. Learn more about this common infection, and who has the highest risk.